KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Notes Payables: 2010-2012

Historic Notes Payables for TherapeuticsMD (TXMD) over the last 1 years, with Dec 2012 value amounting to $3.1 million.

  • TherapeuticsMD's Notes Payables rose 44.28% to $3.1 million in Q4 2012 from the same period last year, while for Dec 2012 it was $3.1 million, marking a year-over-year increase of 44.28%. This contributed to the annual value of $3.1 million for FY2012, which is 44.28% up from last year.
  • TherapeuticsMD's Notes Payables amounted to $3.1 million in Q4 2012, which was down 0.00% from $3.1 million recorded in Q3 2012.
  • TherapeuticsMD's 5-year Notes Payables high stood at $3.1 million for Q2 2012, and its period low was $99,000 during Q2 2011.
  • For the 3-year period, TherapeuticsMD's Notes Payables averaged around $1.9 million, with its median value being $2.1 million (2011).
  • Data for TherapeuticsMD's Notes Payables shows a peak YoY soared of 3,033.33% (in 2012) over the last 5 years.
  • TherapeuticsMD's Notes Payables (Quarterly) stood at $543,531 in 2010, then skyrocketed by 295.56% to $2.1 million in 2011, then skyrocketed by 44.28% to $3.1 million in 2012.
  • Its last three reported values are $3.1 million in Q4 2012, $3.1 million for Q3 2012, and $3.1 million during Q2 2012.